[Federal Register: May 7, 2003 (Volume 68, Number 88)]
[Notices]
[Page 24483-24485]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07my03-89]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 03057]
Cooperative Agreement for a National Poison Prevention and
Control Program; Notice of Availability of Funds
A. Authority and Catalog of Federal Domestic Assistance Number
This program is authorized under section 301(a), 317(k)(2), 391,
392, and 394A [42 U.S.C. 241(a), 247b(k)(2), 280b, 280b-1, 280b-3] of
the Public Health Service Act, as amended. The Catalog of Federal
Domestic Assistance number is 93.136.
B. Purpose
The Centers for Disease Control and Prevention (CDC) and Health
Resources Services Administration (HRSA) announce the availability of
fiscal year (FY) 2003 funds for a cooperative agreement program for a
National Poison Prevention and Control Program. This program addresses
the ``Healthy People 2010'' focus area of Injury and Violence
Prevention.
The purpose of the program is to support an integrated system of
poison prevention and control services including the following:
Completing implementation of and maintaining the nationwide toll-free
number for poison control services; developing, implementing, and
evaluating prevention and public awareness activities associated with
the toll-free number; and sustaining improvements to the national Toxic
Exposure Surveillance System (TESS).
Measurable outcomes of the program will be in alignment with one or
more of the following performance goals for the NCIPC: (1) Increase the
capacity of injury prevention and control programs to address the
prevention of injuries and violence; (2) monitor and detect fatal and
non-fatal injuries; and (3) conduct a targeted program of research to
reduce injury-related death and disability.
C. Eligible Applicants
Applications may be submitted by public and private nonprofit
organizations, faith-based and community-based organizations, and by
governments and their agencies; that is, universities, colleges,
research institutions, hospitals, other public and private nonprofit
organizations, State and local governments or their bona fide agents,
and Federally recognized Indian tribal governments, Indian tribes, or
Indian tribal organizations.
Note: Title 2 of the United States Code section 1611 states
that an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant or loan.
D. Funding
Availability of Funds
Up to $3,900,000 of FY 2003 funds are available to fund one award.
It is expected that the award will begin on or about September 14,
2003, and will be made for a 12-month budget period within a project
period of up to two years. Funding estimates may change.
Continuation awards within an approved project period will be made
on the basis of satisfactory progress as evidenced by required reports
and the availability of funds.
Recipient Financial Participation
Matching funds are not required for this program.
E. Program Requirements
In conducting the activities to achieve the purpose of this
program, the recipient will be responsible for the activities listed in
1. Recipient Activities and CDC, in consultation with HRSA, will be
responsible for the activities in 2. CDC Activities.
1. Recipient Activities
(a) Develop a plan to improve the current national
toxicosurveillance system, with a focus on improvement of data
collection and coding at a select sample of poison control centers.
(b) Implement and maintain the nationwide toll-free telephone
number for poison control services.
(c) Develop and implement a national public service media campaign
to familiarize health care professionals, public health professionals,
and the public with poison control services. Establish a media campaign
stakeholder committee, comprised of poison control center health
educators, state health department injury prevention professionals, and
representatives from relevant national organizations, to guide this
effort.
(d) Promote broad use of the toll-free number by poison control
centers, professionals, and the public by using materials developed by
the American Association of Poison Control Centers (AAPCC) in 2002.
(e) Conduct an independent evaluation of materials developed in
2002, such as English- or Spanish-language promotional brochures or
preschool education materials. Use formative research methods to test
effectiveness in target audiences
(f) Respond to the request for interim reports to assure progress
on the objectives of the cooperative agreement is being made; and meet,
semiannually, with CDC and HRSA staff to identify and address problems.
2. CDC Activities
(a) Provide coordination between the grantee and HRSA, on all
aspects of recipient activities.
(b) Collaborate in the evaluation of the improvements of data
collection at a sample of poison control centers.
(c) Evaluate coding at a select sample of poison control centers.
(d) Provide technical assistance for the effective planning and
management of the development and implementation of the public service
media campaign.
(e) Serve, with HRSA staff, as ex-officio members of the media
campaign stakeholder committee.
F. Content
Applications
The Program Announcement title and number must appear in the
application. Use the information in the Program Requirements, Other
Requirements, and Evaluation Criteria sections to develop the
application content. Your application will be evaluated on the criteria
listed, so it is important to follow them in developing your program
plan. The narrative should be no more than 30 double-spaced pages,
printed on one side, with one-inch margins, and unreduced 12-point
font.
The narrative should consist of:
1. Abstract: A one page abstract and summary of the proposed
effort.
2. Background and Need: Application should describe the background
and need for an integrated program of poison prevention and control
services including the following: Maintaining the nationwide toll-free
number for
[[Page 24484]]
poison control services; developing, implementing, and evaluating
prevention and public awareness activities associated with the toll-
free number; and sustaining improvements to the national Toxic Exposure
Surveillance System (TESS).
3. Methods: Describe activities required to implement an integrated
system of poison prevention and control services, as mentioned in the
purpose section of this announcement. Provide (a) goals and objectives
for implementation, and (b) a two-year timeline for implementation of
activities that is logically sequenced. Describe the coordination of
the poison control centers and other organizations that will
participate and how this will occur. Include letters of support from
all involved individuals and organizations.
Describe how you have addressed the CDC Policy requirements
regarding the inclusion of women, ethnic, and racial groups in the
proposed research. This includes:
(a) The proposed plan for the inclusion of both sexes and racial
and ethnic minority populations for appropriate representation.
(b) The proposed justification when representation is limited or
absent.
(c) A statement as to whether the design of the study is adequate
to measure differences when warranted.
(d) A statement as to whether the plans for recruitment and
outreach for study participants include the process of establishing
partnerships with community(ies) and recognition of mutual benefits.
4. Objectives: Describe long- and short-term objectives that are
specific, measurable, attainable, and realistic. Process and outcome
objectives should be designed to accomplish all activities of the
program during the project period.
5. Evaluation: Design an evaluation to document program process and
effectiveness in achieving objectives to deliver poison prevention and
control services. Document staff availability, expertise, and capacity
to perform this evaluation.
6. Staff and Resources: Describe the responsibilities of the
program coordinator and each of the other staff members responsible for
carrying out the program, including experience, professional education,
and time devoted to the program. A curriculum vita should be included
for each critical staff member.
7. Budget: Include a detailed budget with accompanying narrative
justifying all individual budget items that make up the total amount of
funds requested. The budget should be consistent with the stated goals
and objectives.
8. Performance Goals: Describe measures of effectiveness that will
demonstrate the accomplishment of the various identified objectives of
the cooperative agreement. Measures of effectiveness must relate to the
performance goals stated in the purpose section of this announcement.
Measures must be objective and quantitative and must measure the
intended outcome.
G. Submission and Deadline
Application Forms
Submit the signed original and two copies of PHS 5161-1 (OMB Number
0920-0428). Forms are available at the following Internet address:
www.cdc.gov/od/pgo/forminfo.htm
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) at: 770-488-2700. Application forms can be mailed to you.
Submission Date, Time and Address:
The application must be received by 4 p.m. Eastern Time. June 23,
2003. Submit the application to: Technical Information Management--
PA03057, CDC Procurement and Grants Office, 2920 Brandywine
Road, Atlanta, GA 30341-4146.
Applications may not be submitted electronically.
CDC Acknowledgment of Application Receipt
A postcard will be mailed by PGO-TIM, notifying you that CDC has
received your application.
Deadline
Applications shall be considered as meeting the deadline if they
are received before 4 p.m. Eastern Time on the deadline date. Any
applicant who sends their application by the United States Postal
Service or commercial delivery services must ensure that the carrier
will be able to guarantee delivery of the application by the closing
date and time. If an application is received after closing due to (1)
carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, CDC will upon receipt of proper
documentation, consider the application as having been received by the
deadline.
Any application that does not meet the above criteria will not be
eligible for competition, and will be discarded. The applicant will be
notified of their failure to meet the submission requirements.
H. Evaluation Criteria
Application
Applicants are required to provide measures of effectiveness that
will demonstrate the accomplishment of the various identified
objectives of the cooperative agreement. Measures of effectiveness must
relate to the performance goals stated in the purpose section of this
announcement. Measures must be objective and quantitative and must
measure the intended outcome. These measures of effectiveness must be
submitted with the application and will be an element of evaluation.
An independent review group appointed by CDC will evaluate each
application against the following criteria:
1. Background and Need (25 percent). The extent to which the
applicant presents an understanding of the need for a national poison
prevention and control program and demonstrates experience in this
area, especially the ability to work with poison control centers and
their key issues, and describes the likely impact of their activities
on this problem.
2. Staff and Resources (25 percent). The extent to which the
applicant can provide adequate facilities, staff and/or collaborators,
including a full-time coordinator and resources to accomplish the
proposed goals and objectives during the project period. The extent to
which the applicant demonstrates staff and/or collaborator
availability, expertise, previous experience, and capacity to perform
the undertaking successfully.
3. Methods (20 percent). The extent to which the applicant provides
a detailed description of all proposed activities and collaboration
needed to achieve each objective and the overall program goal(s). The
extent to which the applicant provides a reasonable logically sequenced
and complete schedule for implementing all activities. The extent to
which position descriptions, lines of command, and collaborations are
appropriate to accomplishing the program goal(s) and objectives.
The extent that the application adequately addresses the CDC Policy
requirements regarding the inclusion of women, ethnic, and racial
groups in the proposed research. This includes:
(a) The proposed plan for the inclusion of both sexes and racial
and ethnic minority populations for appropriate representation.
(b) The proposed justification when representation is limited or
absent.
[[Page 24485]]
(c) A statement as to whether the design of the study is adequate
to measure differences when warranted.
(d) A statement as to whether the plans for recruitment and
outreach for study participants include the process of establishing
partnerships with community(ies) and recognition of mutual benefits.
4. Objectives (10 percent). The extent to which the applicant
describes long and short term objectives that are specific, measurable,
attainable, and realistic. The extent to which objectives are time-
framed process and outcome objectives designed to accomplish all
activities of the program.
5. Evaluation (10 percent). The extent to which the proposed
evaluation plan is detailed and capable of documenting program process
and outcome measures. The extent to which the applicant demonstrates
staff and/or collaborator availability, expertise, and capacity to
perform the evaluation.
6. Performance Goals (10 percent). The extent to which the
applicant provides measures of effectiveness that will demonstrate the
accomplishment of the various identified objectives of the cooperative
agreement. Measures of effectiveness must relate to the performance
goals stated in the purpose section of this announcement. Measures must
be objective and quantitative and must measure the intended outcome.
7. Budget and Justification (Not Scored). The extent to which the
applicant provides a detailed budget and narrative justification
consistent with the stated objectives and planned program activities.
8. Does the application adequately address the requirements of
Title 45 CFR Part 46 for the protection of human subjects? Not scored;
however, an application can be disapproved if the research risks are
sufficiently serious and protection against risks is so inadequate as
to make the entire application unacceptable.
I. Other Requirements
Technical Reporting Requirements
Provide CDC with original plus two copies of:
1. Interim progress report, by April 15th. The progress report will
serve as your non-competing continuation application, and must contain
the following elements:
a. Current Budget Period Activities Objectives.
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Detailed Line-Item Budget and Justification.
e. Additional Requested Information.
2. Financial status report, no more than 90 days after the end of
the budget period.
3. Final financial and performance reports, no more than 90 days
after the end of the project period.
Send all reports to the Grants Management Specialist identified in
the ``Where to Obtain Additional Information'' section of this
announcement.
Additional Requirements
The following additional requirements are applicable to this
program. For a complete description of each, see Attachment I of the
program announcement, as posted on the CDC Web site.
AR-7--Executive Order 12372 Review
AR-8--Public Health System Reporting Requirements
AR-9--Paperwork Reduction Act Requirements
AR-10--Smoke-Free Workplace Requirements
AR-11--Healthy People 2010
AR-12--Lobbying Restrictions
AR-13--Prohibition on Use of CDC Funds for Certain Gun Control
Activities
AR-14--Accounting System Requirements
AR-15--Proof of Non-Profit Status
J. Where To Obtain Additional Information
This and other CDC announcements, the necessary applications, and
associated forms can be found on the CDC Web site, Internet address:
http://www.cdc.gov. Click on ``Funding'' then ``Grants and Cooperative
Agreements''.
For general questions about this announcement, contact: Technical
Information Management, CDC Procurement and Grants Office, 2920
Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2700.
For business management and budget assistance, contact: Nancy
Pillar, Grants Management Specialist, Procurement and Grants Office,
Centers for Disease Control and Prevention, 2920 Brandywine Road,
Atlanta, GA 30341-4146, Telephone: 770-488-2721, E-mail address:
nfp6@cdc.gov. For program technical assistance, contact: Stacy L. Harper, Centers
for Disease Control and Prevention, National Center for Injury
Prevention and Control, 4770 Buford Highway NE., Mailstop F41, Atlanta,
GA 30341-3724, Telephone: 770-488-4031, E-mail address:
SLHarper@cdc.gov.
Dated: May 1, 2003.
Edward Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 03-11262 Filed 5-6-03; 8:45 am]
BILLING CODE 4163-18-P